GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Healthy Extracts Inc (OTCPK:HYEX) » Definitions » Debt-to-EBITDA

Healthy Extracts (Healthy Extracts) Debt-to-EBITDA : -0.36 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Healthy Extracts Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Healthy Extracts's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.16 Mil. Healthy Extracts's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Healthy Extracts's annualized EBITDA for the quarter that ended in Mar. 2024 was $-3.27 Mil. Healthy Extracts's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was -0.35.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Healthy Extracts's Debt-to-EBITDA or its related term are showing as below:

HYEX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.65   Med: -0.28   Max: 3.62
Current: -0.49

During the past 10 years, the highest Debt-to-EBITDA Ratio of Healthy Extracts was 3.62. The lowest was -0.65. And the median was -0.28.

HYEX's Debt-to-EBITDA is ranked worse than
100% of 659 companies
in the Drug Manufacturers industry
Industry Median: 1.71 vs HYEX: -0.49

Healthy Extracts Debt-to-EBITDA Historical Data

The historical data trend for Healthy Extracts's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthy Extracts Debt-to-EBITDA Chart

Healthy Extracts Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.62 -0.07 -0.18 -0.65 -0.50

Healthy Extracts Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.55 -0.23 -1.13 -0.95 -0.36

Competitive Comparison of Healthy Extracts's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthy Extracts's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Healthy Extracts's Debt-to-EBITDA falls into.



Healthy Extracts Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Healthy Extracts's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.128 + 0) / -2.242
=-0.50

Healthy Extracts's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.161 + 0) / -3.272
=-0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Healthy Extracts  (OTCPK:HYEX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Healthy Extracts Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Healthy Extracts's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthy Extracts (Healthy Extracts) Business Description

Traded in Other Exchanges
N/A
Address
7375 Commercial Way, Suite 125, Henderson, NV, USA, 89011
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol and cardiovascular health. Its products are distributed in the United States and Mexico. The company's operating segment includes Health Supplements and Corporate. It generates maximum revenue from the Health Supplements segment.
Executives
Robert Michael Madden officer: Chief Financial Officer 5269 SOUTH ALVERA CIR, SALT LAKE CITY UT 84117
Croyle William Russell Jr director 1 SILVERMOUND, LITTLETON CO 80127
Kevin Pitts 10 percent owner, officer: President 3664 CHRISTY RIDGE RD., SEDALIA CO 80135
Sanjeevkumar Ratanshi Javia director, officer: President 7161 E. RANCHO VISTA DRIVE, SUITE 3008, SCOTTSDALE AZ 85251
Patrick Stiles director, 10 percent owner, officer: President, CEO 10300 W. CHARLESTON, LAS VEGAS NV 89135
Joseph Nejman director, 10 percent owner, officer: President 555 BRYANT ST., SUITE 555, PALO ALTO CA 94301
William C Bossung director, 10 percent owner, officer: CFO and Secretary 10300 W. CHARLESTON BLVD., STE. 13-378, LAS VEGAS NV 89135
Brian J Dunn director, 10 percent owner 7075 FLYING CLOUD DRIVE, EDEN PRAIRIE MN 55344
Fred Covely director, 10 percent owner, officer: President and CEO 1508 GRANDVIEW RD., VISTA CA 92084

Healthy Extracts (Healthy Extracts) Headlines

From GuruFocus